While serum neutralizing and IgG antibody responses are rarely correlated with protection against infection and onsets of most enteric virus infections [22, 24–26], serum or mucosal IgA antibody levels have been used to predict both vaccine efficacy and the immune status of individuals or herds against enteric infectious diseases such as rotavirus infection [25]. This evidence concerns the gene CD79A and infection.